Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype
Tóm tắt
Recently, unprecedented drops in breast cancer incidence have been reported for populations of mostly White European descent. Incidence patterns in non-White racial/ethnic groups are less described. Therefore, we examined population-based breast cancer incidence trends separately for US Asian/Pacific Islander, Hispanic, African-American, and non-Hispanic White women by etiologically relevant tumor subtype characteristics, including hormone receptor status, histology, size, and in situ behavior. We obtained breast cancer data from 13 Surveillance, Epidemiology, and End Results (SEER) cancer registries to calculate age-adjusted incidence rates and trends, stratified by race/ethnicity and tumor subtype for the period 1992–2004. Detailed analyses were limited to women 50 years old or older. Joinpoint regression was used to assess incidence trends by annual quarter of diagnosis. Between 2001 and 2004, incidence rates of invasive breast cancer in women 50 years old or older declined appreciably among Asians/Pacific Islanders (-8.5%) and Hispanics (-2.9%) and were stable in African-Americans (+0.5%), reductions substantially lower than those observed among non-Hispanic Whites (-14.3%). In Asian/Pacific Islander women, perceptible but statistically nonsignificant decreases were observed for hormone receptor-positive, lobular, and small tumors only. Rates of hormone receptor-negative tumors increased among African-Americans (26.1%) and Hispanics (26.9%) during 2001–2004. Incidence trends in most groups, except African-American women, peaked between 1999 and mid-2002. Rates of in situ cancer remained stable in all groups. Recently reported reductions in breast cancer incidence varied considerably by race/ethnicity. These patterns are consistent with documented racial/ethnic differences in the prevalence and discontinuation of hormone therapy (HT) after July 2002 but do not correspond as well to patterns of mammography use in these groups. The data presented in this analysis provide further evidence that population-level HT use is a major influence on population-level rates of particular breast cancer subtypes, especially receptor-positive tumors.
Tài liệu tham khảo
citation_journal_title=N Engl J Med; citation_title=The decrease in breast-cancer incidence in 2003 in the United States; citation_author=PM Ravdin, KA Cronin, N Howlader, CD Berg, RT Chlebowski, EJ Feuer, BK Edwards, DA Berry; citation_volume=356; citation_publication_date=2007; citation_pages=1670-1674; citation_doi=10.1056/NEJMsr070105; citation_id=CR1
citation_journal_title=Breast Cancer Res; citation_title=Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women; citation_author=A Jemal, E Ward, MJ Thun; citation_volume=9; citation_publication_date=2007; citation_pages=R28; citation_doi=10.1186/bcr1672; citation_id=CR2
citation_journal_title=J Clin Oncol; citation_title=Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence; citation_author=CA Clarke, SL Glaser, CS Uratsu, JV Selby, LH Kushi, LJ Herrinton; citation_volume=24; citation_publication_date=2006; citation_pages=e49-50; citation_doi=10.1200/JCO.2006.08.6504; citation_id=CR3
citation_journal_title=J Clin Oncol; citation_title=Regional Changes in Hormone Therapy Use and Breast Cancer Incidence, California, 2001–2004; citation_author=AS Robbins, CA Clarke; citation_volume=25; citation_publication_date=2007; citation_pages=3437-3439; citation_doi=10.1200/JCO.2007.11.4132; citation_id=CR4
citation_journal_title=J Natl Cancer Inst; citation_title=Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status; citation_author=AG Glass, JV Lacey, JD Carreon, RN Hoover; citation_volume=99; citation_publication_date=2007; citation_pages=1152-1161; citation_doi=10.1093/jnci/djm059; citation_id=CR5
Katalinic A, Rawal R: Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2007 Apr 24.,
citation_journal_title=J Natl Cancer Inst; citation_title=Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population; citation_author=K Kerlikowske, DL Miglioretti, DS Buist, R Walker, PA Carney; citation_volume=99; citation_publication_date=2007; citation_pages=1335-1339; citation_doi=10.1093/jnci/djm111; citation_id=CR7
Johnston M: Breast cancer drop linked to fall in use of HRT. New Zealand Herald. 20 December, 2006, [
http://www.nzherald.co.nz/section/1/story.cfm?c_id=1&objectid=10416198
]
citation_journal_title=N Engl J Med; citation_title=A decline in breast-cancer incidence; citation_author=EV Kliewer, AA Demers, ZJ Nugent; citation_volume=357; citation_publication_date=2007; citation_pages=509-510; citation_doi=10.1056/NEJMc071391; citation_id=CR9
citation_journal_title=N Engl J Med; citation_title=A decline in breast-cancer incidence; citation_author=PH Zahl, J Maehlen; citation_volume=357; citation_publication_date=2007; citation_pages=510-511; citation_id=CR10
citation_journal_title=JAMA; citation_title=Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial; citation_author=JE Rossouw, GL Anderson, RL Prentice, AZ LaCroix, C Kooperberg, ML Stefanick, RD Jackson, SA Beresford, BV Howard, KC Johnson; citation_volume=288; citation_publication_date=2002; citation_pages=321-333; citation_doi=10.1001/jama.288.3.321; citation_id=CR11
citation_journal_title=JAMA; citation_title=National use of postmenopausal hormone therapy: annual trends and response to recent evidence; citation_author=AL Hersh, ML Stefanick, RS Stafford; citation_volume=291; citation_publication_date=2004; citation_pages=47-53; citation_doi=10.1001/jama.291.1.47; citation_id=CR12
citation_journal_title=Obstet Gynecol; citation_title=Hormone therapy prescribing patterns in the United States; citation_author=DS Buist, KM Newton, DL Miglioretti, K Beverly, MT Connelly, S Andrade, CL Hartsfield, F Wei, KA Chan, L Kessler; citation_volume=104; citation_publication_date=2004; citation_pages=1042-1050; citation_doi=10.1097/01.AOG.0000143826.38439.af; citation_id=CR13
citation_journal_title=J Womens Health (Larchmt); citation_title=The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program; citation_author=JJ Hillman, IH Zuckerman, E Lee; citation_volume=13; citation_publication_date=2004; citation_pages=986-992; citation_doi=10.1089/jwh.2004.13.986; citation_id=CR14
citation_journal_title=Pharmacoepidemiol Drug Saf; citation_title=Use of menopausal hormones in the United States, 1992 through June, 2003; citation_author=DK Wysowski, LA Governale; citation_volume=14; citation_publication_date=2005; citation_pages=171-176; citation_doi=10.1002/pds.985; citation_id=CR15
citation_journal_title=Pharmacoepidemiol Drug Saf; citation_title=Use of postmenopausal hormone therapy since the Women's Health Initiative findings; citation_author=JP Kelly, DW Kaufman, L Rosenberg, K Kelley, SG Cooper, AA Mitchell; citation_volume=14; citation_publication_date=2005; citation_pages=837-842; citation_doi=10.1002/pds.1103; citation_id=CR16
citation_journal_title=J Clin Oncol; citation_title=Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998; citation_author=CI Li, JR Daling, KE Malone; citation_volume=21; citation_publication_date=2003; citation_pages=28-34; citation_doi=10.1200/JCO.2003.03.088; citation_id=CR17
citation_journal_title=JAMA; citation_title=Trends in incidence rates of invasive lobular and ductal breast carcinoma; citation_author=CI Li, BO Anderson, JR Daling, RE Moe; citation_volume=289; citation_publication_date=2003; citation_pages=1421-1424; citation_doi=10.1001/jama.289.11.1421; citation_id=CR18
citation_journal_title=Cancer Epidemiol Biomarkers Prev; citation_title=Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older; citation_author=CI Li, KE Malone, JR Daling; citation_volume=11; citation_publication_date=2002; citation_pages=601-607; citation_id=CR19
citation_journal_title=Breast Cancer Res Treat; citation_title=Distinct incidence patterns among in situ and invasive breast carcinomas, with possible etiologic implications; citation_author=WF Anderson, KC Chu, SS Devesa; citation_volume=88; citation_publication_date=2004; citation_pages=149-159; citation_doi=10.1007/s10549-004-1483-9; citation_id=CR20
citation_journal_title=Eur J Cancer; citation_title=Molecular portraits of breast cancer: tumour subtypes as distinct disease entities; citation_author=T Sorlie; citation_volume=40; citation_publication_date=2004; citation_pages=2667-2675; citation_doi=10.1016/j.ejca.2004.08.021; citation_id=CR21
citation_journal_title=N Engl J Med; citation_title=A decline in breast-cancer incidence; citation_author=LB Signorello, RE Tarone; citation_volume=357; citation_publication_date=2007; citation_pages=512-513; citation_id=CR22
Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence – SEER 13 Regs Public-Use, Nov 2006 Sub (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April based on the November 2006 submission. [
http://www.seer.cancer.gov
]
citation_journal_title=Cancer Epidemiol Biomarkers Prev; citation_title=The surveillance, epidemiology, and end results program: a national resource; citation_author=BF Hankey, LA Ries, BK Edwards; citation_volume=8; citation_publication_date=1999; citation_pages=1117-1121; citation_id=CR24
citation_journal_title=Stat Med; citation_title=Permutation tests for joinpoint regression with applications to cancer rates; citation_author=HJ Kim, MP Fay, EJ Feuer, DN Midthune; citation_volume=19; citation_publication_date=2000; citation_pages=335-351; citation_doi=10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; citation_id=CR25
citation_journal_title=Am J Epidemiol; citation_title=Graphical presentation of trends in rates; citation_author=SS Devesa, J Donaldson, T Fears; citation_volume=141; citation_publication_date=1995; citation_pages=300-304; citation_doi=10.1093/aje/141.4.300; citation_id=CR26
citation_journal_title=Ann Intern Med; citation_title=Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results; citation_author=JS Haas, CP Kaplan, EP Gerstenberger, K Kerlikowske; citation_volume=140; citation_publication_date=2004; citation_pages=184-188; citation_doi=10.7326/0003-4819-140-3-200402030-00009; citation_id=CR27
citation_journal_title=JAMA; citation_title=Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group; citation_author=S Hulley, D Grady, T Bush, C Furberg, D Herrington, B Riggs, E Vittinghoff; citation_volume=280; citation_publication_date=1998; citation_pages=605-613; citation_doi=10.1001/jama.280.7.605; citation_id=CR28
citation_journal_title=Mayo Clin Proc; citation_title=The Women's Health Initiative: a heart-to-HRT conversation; citation_author=LA Fitzpatrick, SC Litin, MR Bell; citation_volume=75; citation_publication_date=2000; citation_pages=559-561; citation_doi=10.4065/75.6.559; citation_id=CR29
Wei F, Miglioretti DL, Connelly MT, Andrade SE, Newton KM, Hartsfield CL, Chan KA, Buist DS: Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr. 2005, 106-112. 10.1093/jncimonographs/lgi047. 35
California Health Interview Survey (CHIS) Public Use Files 2003, 2005. [
http://www.chis.ucla.edu
]
citation_journal_title=Cancer; citation_title=Reported drop in mammography: is this cause for concern?; citation_author=N Breen, AC K, HI Meissner, SH Taplin, FK Tangka, JA Tiro, TS McNeel; citation_volume=109; citation_publication_date=2007; citation_pages=2405-2409; citation_doi=10.1002/cncr.22723; citation_id=CR32
citation_journal_title=Cancer Causes Control; citation_title=Declines in breast cancer after the WHI: apparent impact of hormone therapy; citation_author=CA Clarke, SL Glaser; citation_volume=18; citation_publication_date=2007; citation_pages=847-852; citation_doi=10.1007/s10552-007-9029-1; citation_id=CR33
citation_journal_title=Womens Health Issues; citation_title=Racial differences in estrogen use among middle-aged and older women; citation_author=BA Bartman, E Moy; citation_volume=8; citation_publication_date=1998; citation_pages=32-44; citation_doi=10.1016/S1049-3867(97)00093-5; citation_id=CR34
citation_journal_title=Am J Epidemiol; citation_title=Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study; citation_author=KM Brett, JH Madans; citation_volume=145; citation_publication_date=1997; citation_pages=536-545; citation_doi=10.1093/oxfordjournals.aje.a009142; citation_id=CR35
citation_journal_title=J Gen Intern Med; citation_title=Ethnic differences in hormone replacement prescribing patterns; citation_author=AF Brown, EJ Perez-Stable, EE Whitaker, SF Posner, M Alexander, J Gathe, AE Washington; citation_volume=14; citation_publication_date=1999; citation_pages=663-669; citation_doi=10.1046/j.1525-1497.1999.10118.x; citation_id=CR36
citation_journal_title=Menopause; citation_title=Health behaviors and other characteristics of women on hormone therapy: results from the Third National Health and Nutrition Examination Survey, 1988–1994; citation_author=RM Brennan, CJ Crespo, J Wactawski-Wende; citation_volume=11; citation_publication_date=2004; citation_pages=536-542; citation_doi=10.1097/01.GME.0000119982.77837.C4; citation_id=CR37
citation_journal_title=J Am Geriatr Soc; citation_title=Postmenopausal hormone replacement therapy use by older Mexican-American women; citation_author=DA Newell, KS Markides, LA Ray, JL Freeman; citation_volume=49; citation_publication_date=2001; citation_pages=1046-1051; citation_doi=10.1046/j.1532-5415.2001.49207.x; citation_id=CR38
citation_journal_title=Menopause; citation_title=The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988–1994; citation_author=D Friedman-Koss, CJ Crespo, MF Bellantoni, RE Andersen; citation_volume=9; citation_publication_date=2002; citation_pages=264-272; citation_doi=10.1097/00042192-200207000-00007; citation_id=CR39
citation_journal_title=BMC Cancer; citation_title=Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors; citation_author=CA Clarke, DM Purdie, SL Glaser; citation_volume=6; citation_publication_date=2006; citation_pages=170; citation_doi=10.1186/1471-2407-6-170; citation_id=CR40
citation_journal_title=JAMA; citation_title=Relationship between long durations and different regimens of hormone therapy and risk of breast cancer; citation_author=CI Li, KE Malone, PL Porter, NS Weiss, MT Tang, KL Cushing-Haugen, JR Daling; citation_volume=289; citation_publication_date=2003; citation_pages=3254-3263; citation_doi=10.1001/jama.289.24.3254; citation_id=CR41
citation_journal_title=Br J Cancer; citation_title=Established breast cancer risk factors by clinically important tumour characteristics; citation_author=M Garcia-Closas, LA Brinton, J Lissowska, N Chatterjee, B Peplonska, WF Anderson, N Szeszenia-Dabrowska, A Bardin-Mikolajczak, W Zatonski, A Blair; citation_volume=95; citation_publication_date=2006; citation_pages=123-129; citation_doi=10.1038/sj.bjc.6603207; citation_id=CR42
citation_journal_title=Lancet Oncol; citation_title=Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis; citation_author=GK Reeves, V Beral, J Green, T Gathani, D Bull; citation_volume=7; citation_publication_date=2006; citation_pages=910-918; citation_doi=10.1016/S1470-2045(06)70911-1; citation_id=CR43
citation_journal_title=Cancer Epidemiol Biomarkers Prev; citation_title=Early life factors in relation to breast cancer risk in postmenopausal women; citation_author=L Titus-Ernstoff, KM Egan, PA Newcomb, J Ding, A Trentham-Dietz, ER Greenberg, JA Baron, D Trichopoulos, WC Willett; citation_volume=11; citation_publication_date=2002; citation_pages=207-210; citation_id=CR44
citation_journal_title=Cancer Epidemiol Biomarkers Prev; citation_title=Postmenopausal estrogen and progestin use in relation to breast cancer risk; citation_author=PA Newcomb, L Titus-Ernstoff, KM Egan, A Trentham-Dietz, JA Baron, BE Storer, WC Willett, MJ Stampfer; citation_volume=11; citation_publication_date=2002; citation_pages=593-600; citation_id=CR45
citation_journal_title=Lancet; citation_title=Breast cancer and hormone-replacement therapy in the Million Women Study; citation_author=V Beral; citation_volume=362; citation_publication_date=2003; citation_pages=419-427; citation_doi=10.1016/S0140-6736(03)14596-5; citation_id=CR46
citation_journal_title=Breast Cancer Res Treat; citation_title=Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome; citation_author=WF Anderson, I Jatoi, SS Devesa; citation_volume=90; citation_publication_date=2005; citation_pages=127-137; citation_doi=10.1007/s10549-004-3777-3; citation_id=CR47
Behavioral Risk Factor Surveillance System (BRFSS). [
http://www.cdc.gov/brfss/
]
citation_inbook_title=Health, United States, 2006, With Chartbook on Trends in the Health of Americans With Special Feature on Pain; citation_publication_date=2006; citation_id=CR49; citation_publisher=National Center for Health Statistics
citation_journal_title=J Natl Cancer Inst; citation_title=Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers; citation_author=PL Porter, AY El-Bastawissi, MT Mandelson, MG Lin, N Khalid, EA Watney, L Cousens, D White, S Taplin, E White; citation_volume=91; citation_publication_date=1999; citation_pages=2020-2028; citation_doi=10.1093/jnci/91.23.2020; citation_id=CR50
citation_journal_title=J Natl Cancer Inst; citation_title=Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population; citation_author=AS Robbins, CA Clarke; citation_volume=99; citation_publication_date=2007; citation_pages=1815; citation_doi=10.1093/jnci/djm209; citation_id=CR51
Surveillance, Epidemiology, and End Results (SEER) Data Access & Quality. [
http://seer.cancer.gov/about/uses.html
]
citation_journal_title=J Clin Oncol; citation_title=Estrogen receptor testing of breast cancer in current clinical practice: what's the question?; citation_author=SJ Schnitt; citation_volume=24; citation_publication_date=2006; citation_pages=1797-1799; citation_doi=10.1200/JCO.2005.05.0666; citation_id=CR53
citation_journal_title=Cancer Causes Control; citation_title=Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies; citation_author=LX Clegg, ME Reichman, BF Hankey, BA Miller, YD Lin, NJ Johnson, SM Schwartz, L Bernstein, VW Chen, MT Goodman; citation_volume=18; citation_publication_date=2007; citation_pages=177-187; citation_doi=10.1007/s10552-006-0089-4; citation_id=CR54
citation_journal_title=Cancer Causes Control; citation_title=Misclassification of race/ethnicity in a population-based cancer registry (United States); citation_author=SL Gomez, SL Glaser; citation_volume=17; citation_publication_date=2006; citation_pages=771-781; citation_doi=10.1007/s10552-006-0013-y; citation_id=CR55
citation_journal_title=Int J Cancer; citation_title=Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California; citation_author=TH Keegan, SL Gomez, CA Clarke, JK Chan, SL Glaser; citation_volume=120; citation_publication_date=2007; citation_pages=1324-1329; citation_doi=10.1002/ijc.22432; citation_id=CR56